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follow-up experiments that would provide
evidence for or against a particular hypoth-
esis. The authors deserve credit for enthusi-
astically tackling complex and often
awkward aspects of human biology and for
writing in an accessible style. Unfortunately,
though, they take their title too literally and
their “just-so stories” end up being as de-
fined: delightful, but empty.
Saheli Sadanand
Yale Graduate School
ofArts and Sciences
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2009. 376 pp. US $50.00 Hardcover.
ISBN: 978-0801891519.
Ethics and Newborn Genetic Screening
addresses the ethical and policy issues sur-
rounding technological advances that have
allowedroutinetestingfordozensofraredis-
eases. This book describes newborn screen-
ingprogramswithanhistoricalarc,depicting
whatisatitsrootaclassiccaseoftechnology
outpacing self-reflection. The arc covers
everything from the original controversial
screeningprogramforphenylketonuriatothe
modern ease of checking as many boxes as
one wishes without adding any considerable
cost or effort. It is sometimes taken for
granted that more testing is better, but this
bookmakesacaseforrationaltesting,outlin-
ing reasons and practical methods to make it
happen at a national level.
The book is a compilation of essays by a
wide variety of experts. Each is concerned
with a very different aspect of newborn
screening.Thevarietyofperspectivesweaves
astorythatiscomplexandsometimescontra-
dictory, but always thought provoking. Some
particularly fascinating chapters are dense
overviewsofentireschoolsofthought,almost
self-contained primers on public health.
A chapter by editor Mary Ann Baily in-
terweaves the issue of fair distribution of test-
ing burdens and benefits with that of
healthcaredistributioningeneral.Thisexposes
one of many odd paradoxes of our healthcare
system:ourwillingnesstospendstateandfed-
eralmoneytotestforconditionsthatourfrag-
mentedsystemwilllaterallowtogountreated.
Our affection for newborns apparently does
not extend to the resulting adults.
Scott Grosse writes a terrific overview
of cost-effectiveness analysis, using exam-
ples of newborn genetic screening as a vehi-
cle to explain this frequently used tool. His
views are balanced by a firsthand perspec-
tive from an advocate for genetic screening,
who is both a concerned mother and geneti-
cist.This could be the most valuable chapter
for those of us with a scientific background,
as her reasoning is rational yet sometimes
contrary to the traditional criteria for good
screening tests.
The opening and closing chapters by the
editors provide the rationale for the compila-
tion,framingthegeneralissuetobediscussed.
The theoretical framework complements
many of the chapters with narrower, more
concretesubjectmatter.Overall,thebookisa
well-assembledtreatmentofnewbornscreen-
ing, sure to spark discussion in medical and
bioethical communities.
Anthony Marfeo, MS4
Yale University School of Medicine
Immunology: Clinical Case Studies
and Disease Pathophysiology. By
Warren Strober and Susan R. Gottes-
man. Somerset, NJ; Wiley-Blackwell;
2009, 432 pp. US $52.95 Paperback.
ISBN: 978-0471326595.
Immunology: Clinical Case Studies and
Disease Pathophysiology is a well-written
transcript that underscores the importance of
understanding basic immunology to transla-
tional modern medicine. Using 26 in-depth
case studies, the reader is familiarized with
immunodeficiency diseases, autoimmunity
disorders, malignancies and immediate hy-
persensitivity, and mast cell disorders. Each
case study is presented in a detailed im-
munological background supported by real
data and handy references. The problem setBook reviews 50
at the end of each chapter, plus full-color
photographs and illustrations, facilitate un-
derstanding of the complex diseases being
discussed.The authors also include a chapter
on laboratory tests used in the diagnosis of
immunological disorders, thereby allowing
the reader to appreciate the importance of
laboratory medicine in clinical outcomes.
The authors execute their case studies well
in the larger context of disease occurrence
in the general population, providing a com-
plete overview of the disease process from
manifestation diagnosis through treatment.
This book is a great study aid and reference
guide for all immunologists. It would make
an ideal text for anyone interested in under-
standing immunological disease from both
diagnosis and treatment standpoints.
UzmaAlam, PhD
Yale University School of Medicine
Department of Epidemiology
and Public Health
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In 1981, history professor James Olson
was diagnosed with epitheliod sarcoma and
in 2000, with brain cancer. As a cancer pa-
tient, he endured radiation therapy,
chemotherapy, brain surgery, and amputa-
tion of his left forearm. He uses his own or-
deal as an illustrative example in Making
Cancer History, a meticulous history of the
institution where he was treated: the Univer-
sity ofTexas M.D.Anderson Cancer Center.
Olson combines biographies of prominent
M.D.Anderson personalities with the global
histories of cancer research and treatment to
show how advancements in basic science
and patient care have reduced suffering and
extended lives. Although he renounces any
claim to being dispassionate about the insti-
tution that saved his life, Olson tells the
story as a historian, not omitting the failures
and controversies that must accompany any
mission as ambitious as curing cancer.
Since its establishment in 1941, the
M.D.Anderson Cancer Center has followed
the philosophy of “treat to cure,” which is
echoedintheircurrentmission:“toeliminate
cancer in Texas, the nation, and the world.”
One of its first presidents, R. Lee Clark,
made plans to repurpose the center should a
cure for cancer be found within the decade.
Such optimism seems incredible, but the
progress Olson documents is a testament to
the vision of the early pioneers. At the time
of the center’s founding, the standard cancer
treatment was radical surgery, which re-
moved the tumor, surrounding tissue and
lymphnodes,andofteninvolvedamputation.
In the years that followed, M.D. Anderson
sought to replace radical surgery with mini-
mally invasive treatments such as
chemotherapy and radiotherapy and became
a world leader in cancer prevention and in-
vestigation of environmental cancer causes.
Through its almost 70-year history,
M.D. Anderson has been headed by only
four individuals, and Olson's book is largely
organized around the administrative eras
represented by these four men. From this
emphasis on leadership emerges one of the
book’s central themes: Discovery does not
happen in isolation, it is a product of institu-
tional culture which is itself the product of
inspired leaders.The administration quickly
recognized that treatment of such a complex
disease requires two-way interaction be-
tween scientists trying to understand the dis-
ease and clinicians who have to face the
human side of cancer. The institutional
structure has been continuously adjusted to
maintain a collaborative, multidisciplinary
environment. Even Olson's occasional diver-
sions into dry details such as hospital fi-
nance andTexas university politics illustrate
the multiple levels on which events and in-
dividuals shape an institution.
Although Making Cancer History ap-
pears to present a limited scope ― the his-
tory of a single hospital and its people ―
Olson’s “biography” shows M.D.Anderson
both as a microcosm for the worldwide
progress against cancer and a model for the